What you need to know
A DCAR is an assessment report developed by an independent HTA group. This occurs after the pre-assessment phase if:
- your application was found suitable for the MSAC process
- you have a ratified PICO confirmation (if your application is on the standard pathway)
- our secretariat has agreed to a DCAR for your application.
Our secretariat will contract a suitable HTA group through a panel of providers.
What you need to do
1. Provide information as needed
Applicant involvement in the development of the DCAR will vary. You may have little to no contact with the HTA group if:
- the ratified PICO confirmation (if applicable) is clear
- supporting evidence is available to the public.
The HTA group may need your input if:
- you hold relevant data such as trial results that are not published
- it has questions about matters in your application form, PICO set or elsewhere.
Your application manager will facilitate all communication between you and the HTA group.
2. Note any relevant new information
Let your application manager know about any new evidence or clinical trial outcomes that have become available since you applied to MSAC.
Next steps
When the DCAR is complete, the HTA group will lodge it with our secretariat. This starts the assessment phase of the MSAC process for your application.
In the next step, you will have an opportunity to respond to the DCAR – this is your pre-ESC response.
Also, for applications on the expedited pathway, our secretariat will publish:
- your application page
- the meeting agenda for your chosen ESC meeting.
This will start consultation on your application.
Contact
Contact your application manager or our secretariat if you have any questions.
